BRCA1 regulates insulin‑like growth factor 1 receptor levels in ovarian cancer

Liu,Bo; Li,Da; Guan,Yi‑Fu

doi:10.3892/ol.2014.1929

BRCA1 regulates insulin‑like growth factor 1 receptor levels in ovarian cancer

Authors:
- Bo Liu
- Da Li
- Yi‑Fu Guan
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, China Medical University, Shenyang, Liaoning 110001, P.R. China, Experimental Research Center, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China
Published online on: February 28, 2014 https://doi.org/10.3892/ol.2014.1929
Pages: 1733-1737

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer 1 (BRCA1) and insulin‑like growth factor 1 receptor (IGF1R) are critical in ovarian cancer progression. However, the crosstalk between the BRCA1 and IGF1R signaling pathways in ovarian cancer remains largely unknown. The effects of BRCA1 on IGF1R were assessed in 121 serous ovarian cancer patients (BRCA1 mutation, n=30; non‑BRCA1 mutation, n=32; hypermethylated BRCA1 promoter, n=28; and non‑methylation, n=31). BRCA1 promoter methylation was analyzed via bisulfite sequencing using primers focused on the core promoter region. The expression levels of BRCA1 and IGF1R were assessed by immunohistochemistry and real‑time polymerase chain reaction. Knockdown and overexpression of BRCA1 were achieved using a lentiviral vector in 293T and SKOV3 ovarian cancer cells, and primary non‑mutated and BRCA1‑mutated ovarian cancer cells. The present study demonstrated that IGF1R expression is increased in non‑BRCA1‑mutated ovarian cancer when compared with adjacent normal tissue. Furthermore, IGF1R levels are additionally significantly elevated in BRCA1 inactivation ovarian cancer (BRCA1 mutation or hypermethylated BRCA1 promoter). In addition, BRCA1 knockdown was found to be an effective method of activating IGF1R expression in non‑BRCA1‑mutated ovarian cancer cells. The observations of the current study indicate that BRCA1 may be a potential trigger that is involved in the transcriptional regulation of IGF1R in the development of ovarian cancer.

View Figures

View References

1	Lech A, Daneva T, Pashova S, et al: Ovarian cancer as a genetic disease. Front Biosci (Landmark Ed). 18:543–563. 2013. View Article : Google Scholar
2	Pruthi S, Gostout BS and Lindor NM: Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer. Mayo Clin Proc. 85:1111–1120. 2010. View Article : Google Scholar : PubMed/NCBI
3	Werner H and Bruchim I: IGF-1 and BRCA1 signalling pathways in familial cancer. Lancet Oncol. 13:e537–e544. 2012. View Article : Google Scholar : PubMed/NCBI
4	Samani AA, Yakar S, LeRoith D and Brodt P: The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev. 28:20–47. 2007. View Article : Google Scholar : PubMed/NCBI
5	Bruchim I and Werner H: Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Targets. 17:307–320. 2013. View Article : Google Scholar : PubMed/NCBI
6	Pfäffle R, Kiess W and Klammt J: Downstream insulin-like growth factor. Endocr Dev. 23:42–51. 2012.
7	Scully R: Histological Typing of Ovarian Tumours. 9. 2nd edition. Springer; Berlin, Germany: 1999, View Article : Google Scholar
8	Bi FF, Li D and Yang Q: Promoter hypomethylation, especially around the E26 transformation-specific motif, and increased expression of poly (ADP-ribose) polymerase 1 in BRCA-mutated serous ovarian cancer. BMC Cancer. 13:902013. View Article : Google Scholar
9	Szlosarek PW, Grimshaw MJ, Kulbe H, Wilson JL, Wilbanks GD, Burke F and Balkwill FR: Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther. 5:382–390. 2006. View Article : Google Scholar : PubMed/NCBI
10	Varley KE, Gertz J, Bowling KM, et al: Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 23:555–567. 2013. View Article : Google Scholar : PubMed/NCBI
11	Hudelist G, Wagner T, Rosner M, et al: Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer. 14:1053–1062. 2007. View Article : Google Scholar
12	Maor S, Yosepovich A, Papa MZ, Yarden RI, Mayer D, Friedman E and Werner H: Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutations. Cancer Lett. 257:236–243. 2007. View Article : Google Scholar : PubMed/NCBI
13	Chen X, Meng Q, Zhao Y, et al: Angiotensin II type 1 receptor antagonists inhibit cell proliferation and angiogenesis in breast cancer. Cancer Lett. 328:318–324. 2013. View Article : Google Scholar : PubMed/NCBI
14	Calvo V and Beato M: BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters. Cancer Res. 71:3422–3431. 2011. View Article : Google Scholar
15	Katiyar P, Ma Y, Riegel A, Fan S and Rosen EM: Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity. Mol Endocrinol. 23:1135–1146. 2009. View Article : Google Scholar : PubMed/NCBI
16	Ansquer Y, Legrand A, Bringuier AF, Vadrot N, Lardeux B, Mandelbrot L and Feldmann G: Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line. Anticancer Res. 25:243–248. 2005.PubMed/NCBI
17	Ma Y, Fan S, Hu C, et al: BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol. 24:76–90. 2010. View Article : Google Scholar : PubMed/NCBI
18	Ma Y, Hu C, Riegel AT, Fan S and Rosen EM: Growth factor signaling pathways modulate BRCA1 repression of estrogen receptor-alpha activity. Mol Endocrinol. 21:1905–1923. 2007. View Article : Google Scholar : PubMed/NCBI
19	Ingle JN, Liu M, Wickerham DL, et al: Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention. Cancer Discov. 3:812–825. 2013. View Article : Google Scholar
20	Nelson AC, Lyons TR, Young CD, Hansen KC, Anderson SM and Holt JT: AKT regulates BRCA1 stability in response to hormone signaling. Mol Cell Endocrinol. 319:129–142. 2010. View Article : Google Scholar : PubMed/NCBI